NDC 72647-373
Deferasirox Oral Granules
Deferasirox
Deferasirox Oral Granules is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Oakrum Pharma, Llc. The primary component is Deferasirox.
| Product ID | 72647-373_262ae7a9-bde8-4e49-b620-c582abdc0bb8 |
| NDC | 72647-373 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferasirox Oral Granules |
| Generic Name | Deferasirox |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-09 |
| Marketing End Date | 2024-01-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA214559 |
| Labeler Name | OAKRUM PHARMA, LLC |
| Substance Name | DEFERASIROX |
| Active Ingredient Strength | 360 mg/1 |
| Pharm Classes | Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC] |
| NDC Exclude Flag | N |